Retrospective analysis of transarterial chemoembolization and sorafenib in Chinese patients with unresectable and recurrent hepatocellular carcinoma

We explored the hypothesis that sorafenib may improve the effect of transarterial chemoembolization (TACE) in patients with recurrent hepatocellular carcinoma (HCC) and that longer sorafenib duration was associated with additional survival benefits. In this retrospective, nested case-controlled stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Xuying, Zhai, Xiaofeng, Yan, Zhenlin, Yang, Pinghua, Li, Jun, Wu, Dong, Wang, Kui, Xia, Yong, Shen, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347807/
https://www.ncbi.nlm.nih.gov/pubmed/27566566
http://dx.doi.org/10.18632/oncotarget.11514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347807/
https://www.ncbi.nlm.nih.gov/pubmed/27566566
http://dx.doi.org/10.18632/oncotarget.11514

Ejemplares similares